Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs

Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs

By: IPP Bureau

Last updated : May 04, 2026 1:37 pm



New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology


Kapil Dev inaugurated the specialised Department of Digital PET-CT and Nuclear Medicine at Mahajan Imaging & Labs’ Pusa Road centre, marking a major expansion in advanced diagnostics and therapy support services.

The newly launched department integrates advanced imaging and nuclear medicine technologies, including a next-generation digital PET-CT system and a high-end gamma camera. The expansion strengthens the centre’s capabilities in oncology, neurology, cardiology, nephrology, and other specialties, while complementing its existing infrastructure that includes 3T MRI, 128-slice cardiac CT, ultrasound, mammography, X-ray, and CBCT services.

The digital PET-CT system combines high-resolution metabolic and anatomical imaging in a single scan, enabling improved detection of small abnormalities. The technology supports complete organ coverage in a single pass, reduces radiation exposure by up to 60%, and enables faster scan times, enhancing both diagnostic accuracy and patient safety.

The gamma camera further expands the centre’s functional imaging and therapy capabilities, supporting cardiac assessments, organ function evaluation, bone lesion detection, and targeted radiation-based treatments for conditions such as thyroid disorders and certain cancers.

The launch comes at a time when demand for early and accurate diagnosis of complex diseases, especially cancer, continues to rise in India. PET-CT imaging also plays an important role in radiation therapy planning, helping clinicians accurately map tumour volumes and monitor treatment response.

Speaking on the occasion, Kapil Dev said, “Ten years ago, many of these advanced diagnostic and treatment capabilities were difficult to imagine, but today they are becoming a reality with the progress we are seeing in medical technology. People often delay tests because of anxiety or hesitation, but early diagnosis can make a real difference. Individuals need to be proactive about their health and not ignore symptoms. The launch of this Nuclear Medicine department reflects not just technological excellence with advanced PET-CT and gamma imaging, but also a thoughtfully designed, patient-friendly environment that puts people at ease. Mahajan Imaging & Labs has combined precision, comfort, and care, creating a space where diagnostics and a reassuring environment come together under one roof.”

Harsh Mahajan, Founder and Chairman of Mahajan Imaging & Labs and Mentor at FICCI Health Sector, said, “The launch of the Department of Digital PET-CT and Nuclear Medicine is an important step in expanding our diagnostic capabilities. With the addition of advanced molecular imaging to our existing radiology services, including 3T MRI and 128-slice CT, we are able to offer a more comprehensive diagnostic ecosystem under one roof. This integrated approach supports the entire clinical pathway, from early detection and accurate diagnosis to staging, therapy planning, and monitoring of treatment response, enabling more informed and personalised care.”

The department also expands Mahajan Imaging & Labs’ nuclear medicine therapy offerings, with specialised outpatient treatments for thyroid conditions, prostate cancer, neuroendocrine tumours, and bone-related complications now available at the Pusa Road centre.

Ritu Verma, Director of Nuclear Medicine and PET-CT at Mahajan Imaging & Labs, said, “The combination of digital PET-CT and gamma camera imaging allows us to detect disease earlier, support precise treatment planning, and monitor response to therapy more effectively. The system offers high-resolution imaging that helps identify small abnormalities with greater clarity, while its extended field of view enables complete organ coverage in a single scan, which is particularly useful in complex cases. The growing role of theranostics, where the same approach is used to both detect and treat disease, is further enabling more personalised and patient-focused care. Together, these capabilities help improve clinical decision-making, treatment outcomes, and continuity of care.”

Ritu Mahajan, Co-founder and Executive Director of Mahajan Imaging & Labs, said, “We know that for many patients, walking into a diagnostic centre can be one of the most anxious moments of their lives. They arrive with fear, with unanswered questions, sometimes with a diagnosis they are not ready to face. It was deeply important to us that the environment itself become part of the healing. The royal blue soothes, the teal reassures, and the warmth of the sustainable materials grounds you in the present moment. When you walk into Pusa Road, we want you to feel, before a single word is spoken, that you are safe, that you are cared for, and that you are not alone.

 

Kapil Dev Mahajan Imaging & Labs Digital PET-CT Nuclear Medicine theranostics oncology diagnostics gamma camera molecular imaging cancer diagnosis radiation therapy planning nuclear medicine therapy 3T MRI cardiac CT precision diagnostics healthcare technology Harsh Mahajan Ritu Verma Ritu Mahajan FICCI Health Sector advanced imaging patient care oncology treatment healthcare infrastructure

First Published : May 04, 2026 12:00 am